Abrams Capital Management’s Celgene Corp CELG Stock Holding History

Abrams Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-6,752,869	Closed	-$671M	–	23
2019 Q3	$671M	Hold	6,752,869	–	–	18.77%	1
2019 Q2	$624M	Hold	6,752,869	–	–	16.96%	1
2019 Q1	$637M	Buy	+6,752,869	New	+$591M	17.89%	1

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Abrams Capital Management's CELG Position: Q4 2019 in Review

Abrams Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,752,869 shares — an estimated $671M sold.

Abrams Capital Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $671M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Abrams Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Abrams Capital Management sold 6,752,869 Celgene Corp shares in Q4 2019, an estimated $671M.
Abrams Capital Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Abrams Capital Management's Celgene Corp position peaked at $671M in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Abrams Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.